MedPath

The effect of aromatherapy with Orange Spring on nausea and vomiting

Phase 3
Conditions
Breast cancer.
Malignant neoplasm of breast
Registration Number
IRCT20240305061177N1
Lead Sponsor
Shiraz University of Medical Sciences
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Pending
Sex
Female
Target Recruitment
100
Inclusion Criteria

Women aged 18- 80 years
Women with a definite diagnosis of breast cancer in stage 2 and 3, without metastasis
Treating with standard and identical AC-T chemotherapy protocol
Women who were receiving chemotherapy and experienced nausea and/or vomiting of any severity
Have at least two remaining chemotherapy courses using similar chemotherapeutic agents
Not pregnant
Being literate in reading and writing
Having a healthy sense of smell and taste according to the patient's self-report
Absence of known mental and Psychiatric diseases according to the patient's self-declaration
No history of allergy to plants and Orang Spring according to the patient's self-report
Not suffering from respiratory diseases such as asthma, allergic diseases and chronic obstructive pulmonary disease according to the patient's self-report.
Using the same anti-nausea and vomiting regimen in all patients
Non-use of other complementary medicine methods at the time of participating in the research
Absence of epilepsy according to the patient's self-report

Exclusion Criteria

Unwillingness to continue participating in the study
Failure to use the aroma according to the program provided to the patient
Concurrent chemotherapy with radiotherapy
Suffering any diseases or conditions that lead to nausea and vomiting, such as liver failure, kidney failure, digestive problems, acute stage of hepatitis B, obstruction of the digestive tract, and brain malignancies according to the patient's self-report.
Anticipatory nausea and vomiting. It means nausea and vomiting that has a psychological aspect and usually occurs a few hours before chemotherapy, which is caused by talking or thinking about chemotherapy.

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
ausea and Vomiting. Timepoint: Up to 5 days after the intervention. Method of measurement: Rhodes nausea and vomiting index.
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath